COCCO, CRISTINA
 Distribuzione geografica
Continente #
EU - Europa 166.834
NA - Nord America 4.970
AS - Asia 2.376
SA - Sud America 410
AF - Africa 42
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 174.659
Nazione #
IT - Italia 165.192
US - Stati Uniti d'America 4.895
CN - Cina 1.038
SG - Singapore 923
SE - Svezia 488
UA - Ucraina 370
BR - Brasile 347
DE - Germania 288
FI - Finlandia 147
VN - Vietnam 145
GB - Regno Unito 107
FR - Francia 76
KR - Corea 60
CA - Canada 45
HK - Hong Kong 42
IN - India 33
JP - Giappone 29
RU - Federazione Russa 29
NL - Olanda 26
AR - Argentina 25
PL - Polonia 23
MX - Messico 20
ZA - Sudafrica 20
ES - Italia 19
AU - Australia 17
BD - Bangladesh 17
TR - Turchia 16
CZ - Repubblica Ceca 13
ID - Indonesia 11
BE - Belgio 10
IQ - Iraq 10
MA - Marocco 10
AT - Austria 9
EC - Ecuador 9
IR - Iran 9
CH - Svizzera 8
EU - Europa 8
IE - Irlanda 8
CL - Cile 7
UZ - Uzbekistan 7
UY - Uruguay 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
MY - Malesia 4
AL - Albania 3
BH - Bahrain 3
KG - Kirghizistan 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
CR - Costa Rica 2
GY - Guiana 2
NO - Norvegia 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KI - Kiribati 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MQ - Martinica 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 174.659
Città #
Cagliari 161.665
Uta 2.989
Fairfield 441
Ashburn 436
Singapore 416
Chandler 412
Nyköping 295
Woodbridge 292
Dallas 262
Ann Arbor 241
Wilmington 233
Boardman 223
Beijing 213
Houston 196
Jacksonville 190
Seattle 182
Cambridge 163
Dearborn 135
Shanghai 127
Los Angeles 115
Santa Clara 88
New York 82
Helsinki 75
Nanjing 69
Hefei 65
Seoul 58
Munich 57
Boston 56
Dong Ket 50
São Paulo 42
Ho Chi Minh City 41
Hong Kong 40
Buffalo 39
The Dalles 37
Rome 36
Guangzhou 35
Redwood City 29
San Diego 27
Tokyo 25
Chicago 24
Tianjin 24
Changsha 23
Milan 22
Nanchang 22
Phoenix 22
Shenyang 22
Verona 21
San Mateo 19
Brooklyn 18
Hanoi 18
Jiaxing 18
Denver 17
Redondo Beach 17
Warsaw 17
Hebei 16
Toronto 16
Amsterdam 15
Atlanta 15
London 15
Sydney 15
Belo Horizonte 14
Jinan 14
Johannesburg 14
Montreal 14
Nuremberg 14
Rio de Janeiro 14
Falls Church 13
Frankfurt am Main 13
Auburn Hills 12
Düsseldorf 12
Orange 12
Orem 12
Council Bluffs 11
Stockholm 11
Turku 11
Brussels 10
Kunming 10
Norwalk 10
Paris 10
Renton 10
Brno 9
Chennai 9
Mountain View 9
Poplar 9
Dublin 8
Jinhua 8
Lappeenranta 8
Leawood 8
Sestu 8
Zhengzhou 8
Curitiba 7
San Francisco 7
Selargius 7
Vienna 7
Arbus 6
Baghdad 6
Casablanca 6
Columbus 6
Fortaleza 6
Hangzhou 6
Totale 170.962
Nome #
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.726
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.723
Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters 4.318
Profiles of VGF peptides in the rat brain and their modulations after Phencyclidine treatment 4.037
Involvement of nigral oxytocin in locomotor activity: a behavioral, immunohistochemical and lesion study in male rats 4.019
Targeting Substantia Nigra through Oxytocin Receptors. 3.828
VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. 3.826
VGF and Type II Diabetes: Decrease of VGF fragment levels in adipose tissues of diet-induced obese mice 3.814
Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding 3.800
Parkinson’s disease: changes in TLQP and related peptide/s in 6-OHDA treated rat and in human plasma 3.698
VGF-peptides in the Siberian hamster 3.655
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain 3.618
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases 3.543
VGF peptides: differential expression in motor neurons, and possible changes in Amyotrophic Lateral Sclerosis (ALS). 3.541
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.469
Selective expression of vgf-derived peptides in gastric endocrine cells: differential modulation of TLQP-peptides by feeding 3.390
VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides? 3.318
Pituitary gonadotropins and autoimmunity 3.294
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.169
VGF peptides in hypothalamus-pituitary axis in the rat estrous cycle 3.160
Attività motoria e interazione tra ossitocina, dopamina ed acido glutammico nella Sostanza Nera del ratto maschio: uno studio comportamentale, immunoistochimico e di lesione 3.141
Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation 3.127
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.100
Oxytocin induces penile erection when injected into the ventral subiculum: role of nitric oxide and glutamic acid 3.047
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.897
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.842
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.831
Oxytocin induces penile erection and yawning when injected into the bed nucleus of the stria terminalis: A microdialysis and immunohistochemical study 2.817
Targeting Substantia Nigra through Oxytocin Receptors 2.692
VGF peptides as novel biomarkers in Parkinson’s disease 2.674
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.672
null 2.647
Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats 2.603
Modulation of the VGF derived peptides NERP-1 and –2 upon salt loading and dehydration: novel actors in water homeostasis? 2.559
Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP 2.440
VGF peptides and peripheral activation of energy expenditure 2.417
VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets 2.333
Multiple immunofluorescence technology 2.321
TLQP 21 and other Pro-VGF peptides: peripheral and central alternative peptide products from the neuro-endocrine vgf gene and evidence for their modulation. 2.313
The hypothalamic-pituitary axis and autoantibody related disorders 2.269
Alzheimer’s disease related vgf-peptide/s in the mammalian nervous system 2.253
The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: a neurochemical, immunohistochemical and behavioral study 2.188
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies 2.168
Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21 2.155
Effect of TLQ-21 peripheral injection on food intake and reproduction mechanisms in female Siberian Hamsters 1.938
Selective VGF-peptide/s changes in human neurodegenerative diseases. 1.933
Novel VGF-derived peptides in homeostatic control: blood and tissue changes of the amidated NERP peptide/s upon salt loading and dehydration 1.909
Dynamic of TLQP-peptides upon fasting 1.822
Analysis of hypothalamic VGF-immunoreactivity in the Siberian Hamster. 1.768
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.721
Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin 1.672
Misurazione dei livelli dei peptidi C-terminali di VGF nel plasma di pazienti affetti dalla malattia di Parkinson per una diagnosi precoce 1.632
Le malattie autoimmuni dell'ipofisi e dell'Ipotalamo 1.454
Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts 1.432
Tissue cryoarraies: a novel approach to autoantibodies detection 1.257
Tunable, colour coded simultaneus viewing in multiple fluorescence: a novel approach to gene-product espression dynamics. 1.223
Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? 1.203
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach 1.165
The novel neuroendocrine peptides “nerp-1” and “nerp-2”: changes in altered water balance 1.144
Median eminence dopaminergic terminals: a novel autoimmune target 1.085
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 1.080
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.005
Embedding media for cryomicrotomy: an applicative reappraisal 998
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type 1 autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation 991
Cellule biocitinate nel pancreas umano 987
Autoimmune target within the hypothalamic median eminence in patients with a polyendocrine disease 984
TLQP-21 changes in response to a glucose load 884
Equipment testing and tuning: the cold-knife cryomicrotome microm HM-560 859
Autoantibodies targets in the hypothalamic-hypophyseal complex: possibile role in type 1 autoimmune polyendocrinopaty with growth arrest 822
VGF peptides upon osmotic stimuli: Changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma 702
Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study 696
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type I autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation. 679
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF 613
Brain-Biomarker Changes in Body Fluids of Patients with Parkinson’s Disease 408
VGF modifications related to nigrostriatal dopaminergic neurodegeneration induced by the pesticide fipronil in adult male rats 387
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 362
Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy Controls 182
The NR4A2/VGF pathway fuels inflammation-induced neurodegeneration via promoting neuronal glycolysis 138
A beginner’s guide to immunohistochemistry 121
NERP-1 modifications in amyotrophic lateral sclerosis 69
Inhibition of α-Glucosidase Activity and Islet Amyloid PolyPeptide Fibril Formation by Rubus ulmifolius Fruit Extract: A Potential Therapeutic Approach for Type 2 Diabetes Mellitus 37
Early Dopaminergic Dysfunction Induces PRO-VGF Changes in Blood and Brain of Rats with Alpha-Synuclein Overexpression 31
VGF INVOLVEMENT ON PARKINSON’S DISEASE 26
VGF AQEE- and GGEE-peptides differentiate between dementia types 23
VGF and Its Derived Peptides in Amyotrophic Lateral Sclerosis 23
Totale 174.917
Categoria #
all - tutte 204.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121.342 0 0 0 0 0 5.847 3.088 3.435 1.472 3.097 2.770 1.633
2021/20229.262 1.461 746 368 782 863 512 581 351 856 1.026 970 746
2022/202312.379 797 1.723 1.833 1.118 851 1.099 641 892 837 955 1.115 518
2023/202411.587 832 616 559 793 1.244 1.734 1.765 831 863 712 816 822
2024/202516.673 2.994 4.325 2.673 2.013 1.092 1.107 1.426 147 246 197 200 253
2025/20262.835 400 290 553 541 631 420 0 0 0 0 0 0
Totale 174.917